'Unacceptable' Medical Deserts Leave Rural Patients With Rare Diseases Stranded.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 4, p. 36
- By:
- Publication type:
- Article
Works matching AU Stonehill, Monica
Results: 38
1
2
'Take Ownership' of Neglected Hepatitis A, E to Head Off Next Public Health Threat.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 4, p. 18
- By:
- Publication type:
- Article
3
Colonoscopy Rescreening Could be Extended for Those With Negative Results, Low CRC Risk.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 3, p. 35
- By:
- Publication type:
- Article
4
US Cases of MASLD Projected to Top 121 Million by 2050 Alongside 55% Spike in MASH.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 3, p. 34
- By:
- Publication type:
- Article
5
Prucalopride Still Effective in CIC Despite Older Age, Unhealthy BMI or Renal Impairment.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 2, p. 37
- By:
- Publication type:
- Article
6
Early Surgery 'Should be Preferred Approach' Over Endoscopy-First in Chronic Pancreatitis.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 2, p. 35
- By:
- Publication type:
- Article
7
GIs Continue to Grapple With Growing Patient Demand, Despite Shrinking Physician Shortage.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 2, p. 18
- By:
- Publication type:
- Article
8
Women Physicians Need to 'Be at the Table, Advocate for Changes' to Thrive in GI.
- Published in:
- 2025
- By:
- Publication type:
- Interview
9
'Only One in Six' Veterans With Chronic HBV Finish HDV Testing Despite Severe Disease Risk.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 1, p. 37
- By:
- Publication type:
- Article
10
Zegocractin 'Holds Promise' for Reducing Organ Failure, Necrosis in Acute Pancreatitis.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 1, p. 32
- By:
- Publication type:
- Article
11
Pharmacotherapy for Alcohol Use Disorder 'Underutilized' in At-Risk Populations.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 1, p. 31
- By:
- Publication type:
- Article
12
Angiotensin Receptor Blockers 'May Not Be Safe,' Worsen Outcomes for Celiac Disease.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 1, p. 30
- By:
- Publication type:
- Article
13
Monthly Efimosfermin Offers 'Rapid, Meaningful' Improvement for MASH, Related Fibrosis.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 1, p. 27
- By:
- Publication type:
- Article
14
ESSENCE: Semaglutide Bests Placebo in MASH Resolution, Fibrosis Improvement at 72 Weeks.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 1, p. 25
- By:
- Publication type:
- Article
15
Anthem Retracts 'Morally Abhorrent' Policy to Put Time Limit on Anesthesia During Surgery.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 1, p. 9
- By:
- Publication type:
- Article
16
A Clear Liquid Diet Prior to GI Endoscopy May be 'More Important' Than Holding GLP-1RAs.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 34
- By:
- Publication type:
- Article
17
GLP-1RAs May Offer 'Hepatoprotective' Benefit for Diabetes, Alcohol-Related Liver Disease.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 32
- By:
- Publication type:
- Article
18
Liver Stiff ness Measurements May 'Personalize' HCC Risk, Surveillance Needs in MASLD.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 28
- By:
- Publication type:
- Article
19
What is Driving 'Disturbing' Rise in Metastatic Stomach Cancer in Young Adults?
- Published in:
- 2024
- By:
- Publication type:
- Interview
20
GIs Clash With GLP-1 Restrictions for Endoscopy, But 'Anesthesiologists Have Final Say'.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 9, p. 18
- By:
- Publication type:
- Article
21
Bariatric Surgery Signifi cantly Reduced Major Adverse Liver Outcomes in MASH Cirrhosis.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 8, p. 19
- By:
- Publication type:
- Article
22
'Unprecedented Level of Fibrosis Improvement' Through 96 Weeks With Efruxifermin for MASH.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 7, p. 36
- By:
- Publication type:
- Article
23
Rifaximin 'Cannot be Recommended' as Antibiotic Prophylaxis for Severe Cirrhosis, Ascites.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 7, p. 35
- By:
- Publication type:
- Article
24
VIDEO: Lifetime Disruptor 'Just Getting Started' in Quest to Elevate Care for IBD Patients.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 7, p. 25
- By:
- Publication type:
- Article
25
'Unequivocally Yes': MASH Therapies Still Needed Despite Boom in GLP-1 Use in Liver Disease.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 7, p. 17
- By:
- Publication type:
- Article
26
FDA Approves Ipsen's Iqirvo 'To Address Unmet Need' in Primary Biliary Cholangitis.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 7, p. 9
- By:
- Publication type:
- Article
27
GLP-1RA Use in MAFLD, Obesity Lowers Mortality, 'Provides Cardiovascular Benefits'.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 6, p. 33
- By:
- Publication type:
- Article
28
VIDEO: 'You Can Make a Big Impact,' Tackle Medical Misinformation With Social Media.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 6, p. 10
- By:
- Publication type:
- Article
29
VIDEO: Childhood Food Insecurity May Play Role in 'Booming' Rise of MASLD.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 5, p. 30
- By:
- Publication type:
- Article
30
Surge in 'Sober Curious' Movement Could Yield Lasting Health Benefits.
- Published in:
- 2024
- By:
- Publication type:
- Interview
31
VIDEO: 'Digestible' New Book Aims to Help People Own Their Gut Health, Debunk Common Myths.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 5, p. 10
- By:
- Publication type:
- Article
32
VIDEO: OK to Switch Patients With IBD From Biologic to Biosimilar ‘At Any Given Time’.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 4, p. 30
- By:
- Publication type:
- Article
33
‘Monumental Occasion’: FDA Approves Madrigal’s Rezdiffra as First Treatment for MASH.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 4, p. 11
- By:
- Publication type:
- Article
34
Q&A: Zymfentra ‘Gives Patients An Option’ for At-Home Maintenance Therapy of IBD.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 3, p. 38
- By:
- Publication type:
- Article
35
VIDEO: Reinforce Self-Care on Individual, System Levels for Clinicians to ‘Flourish’.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 3, p. 36
- By:
- Publication type:
- Article
36
VIDEO: Women, Supportive Allies Must Join Forces to ‘Break Gender Gap Ceiling’ in GI.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 3, p. 36
- By:
- Publication type:
- Article
37
Takeda’s Eohilia Rebounds to Win FDA Approval as ‘First and Only’ Oral Therapy for EoE.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 3, p. 7
- By:
- Publication type:
- Article
38
Pegozafermin Improves Stage 4 Fibrosis, Noninvasive Markers in MASH Patients.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 1, p. 30
- By:
- Publication type:
- Article